| Absorption |
| Blood-Brain Barrier | BBB+ | 0.5663 |
| Human Intestinal Absorption | HIA+ | 0.9878 |
| Caco-2 Permeability | Caco2+ | 0.7801 |
| P-glycoprotein Substrate | Substrate | 0.5422 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9619 |
| Non-inhibitor | 0.9432 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9058 |
| Distribution |
| Subcellular localization | Mitochondria | 0.8053 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7113 |
| CYP450 2D6 Substrate | Non-substrate | 0.8963 |
| CYP450 3A4 Substrate | Non-substrate | 0.6600 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.9107 |
| CYP450 2C9 Inhibitor | Inhibitor | 0.8825 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.6118 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.5367 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.5424 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.6156 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9449 |
| Non-inhibitor | 0.8974 |
| AMES Toxicity | AMES toxic | 0.9108 |
| Carcinogens | Non-carcinogens | 0.8902 |
| Fish Toxicity | High FHMT | 0.9390 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9783 |
| Honey Bee Toxicity | High HBT | 0.6977 |
| Biodegradation | Not ready biodegradable | 0.7857 |
| Acute Oral Toxicity | III | 0.6654 |
| Carcinogenicity (Three-class) | Non-required | 0.6367 |